Constitutive activation of KRAS and persistent stimulation of downstream pathways sustains tumor cell proliferation, migration, metastasis and metabolic reprogramming, along with the evasion of the anti-tumor immune response [31,32,33,34,35,36,37,38]. The gene discussed is KRAS; the disease is neoplasm.